Related Experiment Video
Updated: Oct 9, 2026
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
Management of anaplastic thyroid cancer
Xavier M Keutgen1, Samira M Sadowski1, Electron Kebebew1
1Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda 20892, Maryland, USA.
Abstract:
Anaplastic thyroid cancer (ATC) is a deadly disease with a dismal prognosis. Molecular analyses of ATC tumors have yielded interesting results, which could help in understanding the underlying mechanisms of this aggressive disease process. Managing ATC can be challenging and includes rapid diagnosis, adequate staging, and interdisciplinary, multimodal treatments to optimize patient outcome. Treatments include surgical resection to gross negative margins when possible, as well as neo- or adjuvant treatment with chemotherapy or external beam radiation (XRT) for locoregional disease. New treatment strategies include evaluating the benefits of vascular disrupting agents and tyrosine kinase inhibitors for advanced ATC with driver mutations, which can be targeted. This review summarizes key concepts in managing ATC.
Insights
Anaplastic thyroid cancer (ATC) is aggressive, requiring prompt diagnosis and multimodal treatment. Emerging therapies target molecular drivers for advanced cases, offering new hope.
Area of Science:
- Oncology
- Molecular Biology
- Medical Research
Background:
- Anaplastic thyroid cancer (ATC) presents a grave prognosis and significant management challenges.
- Understanding the molecular underpinnings of ATC is crucial for developing effective strategies.
- Current treatment paradigms involve surgery, chemotherapy, and external beam radiation (XRT).
Purpose of the Study:
- To review key concepts in the management of anaplastic thyroid cancer.
- To highlight the importance of molecular analyses in understanding ATC.
- To discuss current and emerging treatment strategies for ATC.
Main Methods:
- Literature review of anaplastic thyroid cancer management.
- Analysis of molecular findings in ATC tumors.
- Summary of treatment modalities including surgery, chemotherapy, XRT, and novel agents.
Main Results:
- Molecular insights are providing a better understanding of ATC's aggressive nature.
- Multimodal treatment approaches are essential for optimizing patient outcomes.
- Targeted therapies, including tyrosine kinase inhibitors, show promise for advanced ATC with specific mutations.
Conclusions:
- Effective ATC management necessitates rapid diagnosis, staging, and interdisciplinary care.
- Novel therapeutic strategies are being explored to improve outcomes for this deadly disease.
- Targeting molecular drivers represents a promising avenue for advanced anaplastic thyroid cancer treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
01:27Hyperthyroidism II: Pathophysiology